Quest Diagnostics (DGX) Asset Writedowns and Impairment (2009 - 2019)

Quest Diagnostics (DGX) has 11 years of Asset Writedowns and Impairment data on file, last reported at $2.0 million in Q4 2019.

• Quarterly Asset Writedowns and Impairment fell 50.0% year-over-year to $2.0 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $11.0 million (up 83.33% YoY) and the FY2024 annual result came in at $5.0 million, up 400.0% from the prior year.
• Asset Writedowns and Impairment slipped to $2.0 million in Q4 2019 per DGX's latest filing, from $4.0 million in the prior quarter.
• The five-year high for Asset Writedowns and Impairment was $86.0 million in Q1 2016, with the low at -$235.0 million in Q4 2016.
• Average Asset Writedowns and Impairment over 5 years is $16.4 million, with a median of $3.5 million recorded in 2017.
• Year-over-year, Asset Writedowns and Impairment tumbled 461.54% in 2016 and jumped 133.33% in 2019.
• Quest Diagnostics' Asset Writedowns and Impairment stood at $65.0 million in 2015, then plunged by 461.54% to -$235.0 million in 2016, then jumped by 101.28% to $3.0 million in 2017, then surged by 33.33% to $4.0 million in 2018, then tumbled by 50.0% to $2.0 million in 2019.
• Business Quant data shows DGX's Asset Writedowns and Impairment at $2.0 million in Q4 2019, $4.0 million in Q3 2019, and $1.0 million in Q2 2019.